文档库

最新最全的文档下载
当前位置:文档库 > 结肠癌干细胞研究进展

结肠癌干细胞研究进展

he m atopoietic ce ll[J].N at M ed,1997,3(7):730-

737.

[2]A-l H a jj M,W i cha M S,Ben it o-H ernandez A,et a.l

P rospecti v e i dentificati on of t u m or i genic breast cancer

ce ll s[J].P roc N atl A cad Sc i U S A,2003,100(7):3983

-3988.

[3]H e mma ti HD,N aK ano I,La zareff J A,e t a.l Cance rous

stem ce ll s can arise from pediatr ic brain t umo rs[J].P roc

N a tlA cad Sc iU S A,2003,100(25):15178-15183. [4]O.B rien CA,Po llett A,G allinger S,D ick J E.A hu m an

co lon cancer cell capab le of initiati ng t u m our grow th i n

i m munodefi c ient m ice[J].N ature,2007,445(7123):

106-110.

[5]R icc-i V iti ani L,L o m ba rdi DG,P il o zzi E,et a.l

Iden tificati on and expansi on of hu m an co l on-cancer-

initiati ng ce lls[J].N ature,2007,445(7123):111-115.

[6]O doux C,F ohrer H,H oppo T,et a.l A stochasti c m ode l for

cancer stem cell o rig i n i n m etastatic co lon cance r[J].

Cancer R es,2008,68(17):6932-6941.

[7]V e r m eu l en L,T oda ro M,de Sousa M e llo F,et a.l S i ng le-

ce ll cloni ng o f co l on cancer stem ce lls revea ls a m ult-i

li neage d ifferen ti ation capac ity[J].P roc N atl A cad Sci U S A,2008,105(36):13427-13432.

[8]Bo m an B M,H uang E.H u m an colon cancer ste m cell s:A

ne w pa radig m i n gastro i ntesti nal onco l ogy[J].J C li n

O nco,l2008,26(17):2828-2838.

[9]Brab letz T,Jung A,Spaderna S,et a.l M i g ra ti ng cancer

stem ce lls:A n integ ra ted concept o f m ali gnant tu m our

prog ressi on[J].N a tR ev Cancer,2005,5(9):744-749.

[10]van de W eter i ng M,Sancho E,V er w e ij C,et a.l T he beta-

cateni n/TCF-4co m plex i m poses a crypt progen itor

phenotype on co l o recta l cance r cells[J].C el,l2002,111

(2):241-250.

[11]杨文君,陈丽荣.上皮间质转化在肿瘤侵袭转移中的

作用[J].实用肿瘤杂志,2008;23(1):86-90. [12]Zhang T,O tevre lT,G ao Z.Ev i dence tha t APC regu l a tes

surv iv i n expression:A po ssi b l e m echanis m contr i buti ng

to the stem ce ll o ri g in o f co lon cance r[J].Cance r R es,

2001,61(24):8664-8667.

[13]Chu P,C lanton D J,Sn i pas TS,et a.l Characte rization of a

subpopu lati on o f colon cancer ce lls w it h stem ce l-l li ke

prope rti es[J].Int J Cancer,2009,124(6):1312-

1321.

[14]van E s J H,van G ij n M E,R icc i o O,et a.l N o tch/g a mm a-

secretase i nh i b ition t urns proliferati ve ce lls i n i ntesti nal

crypts and adenomas i nto gob let cell s[J].N ature,

2005,435(7044):959-963.

[15]H e XC,Z hang J,Tong WG,et a.l B M P s i gna ling i nh i b i ts

i ntesti nal ste m ce ll sel-f rene w a l through suppression o f

W nt-beta-ca ten i n s i gna li ng[J].N a t G enet,2004,36

(10):1117-1121.

[16]汪春良,夏良,孙玉岭.结肠癌患者术前外周静脉

血CD133阳性细胞数量与血清癌胚抗原及肿瘤进展

的关系[J].实用医学杂志,2008;24(5):767-770. [17]L i n E H,H assan M,L i Y,e t a.l E levated circu l a ti ng

endothelial progen itor ma rker CD133m esseng er RNA

levels predict colon cancer recurrence[J].Cancer,

2007,110(3):534-542.

[18]Huang E H,H ynes M J,Zhang T,et a.l A l dehyde

dehydrogenase1is a m arker f o r nor m a l and m ali gnant

hum an co l onic stem ce lls(SC)and tracks SC

overpopu l a ti on dur i ng co l on tu m or i genesis[J].Cancer

R es,2009,69(8):3382-3389.

[19]H orst D,K r i eg l L,Eng el J,et a.l CD133expression is an

independent prognostic m a rker for low surv ival in

co l o rec tal cancer[J].B r J Cancer,2008,99(8):1285

-1289.

[20]X u M,Y uan Y,X i a Y,et a.l M onoc l onal anti body CC188

b i nds a carbohydrate ep it ope expressed on the s u rface o f

both co lorecta l cance r stem ce lls and their d ifferentiated

prog eny[J].C li n Cancer R es2008,14(22):7461-

7469.

[21]T odaro M,A lea M P,D i Ste f ano A B,et a.l Co l on cancer

stem cell s dictate t u m or grow th and resist ce ll death by

produc ti on o f i nte rleuki n-4[J].Ce ll Ste m Ce l,l2007,1

(4):389-402.

[22]Huang EH,W icha M S.Co l on cancer stem cells:

i m plica tions for preventi on and therapy[J].T rendsM o l

M ed,2008,14(11):503-510.

[23]Shm el kov S V,Butler J M,H ooper AT,et a.l CD133

expressi on is not restr i cted to stem cell s,and both

CD133+and CD133-m e tasta ti c co l on cancer ce lls

initiate tu m ors[J].J C li n Invest,2008,118(6):2111-

2120.

[24]Ie ta K,T anaka F,H a raguchi N,et a.l B io l og i ca l and

geneti c characteristi cs o f tu mo ri n iti a ti ng ce lls i n co l on

cance r[J].A nn Surg O nco,l2008,15(2):638-648. [25]H araguch i N,Ohku m a M,Sakash ita H,e t a.l CD133+

CD44+populati on effi c ientl y enr i ches co l on cancer

initiati ng cell s[J].A nn Surg Onco,l2008,15(10):

2927-2933.

[26]D a lerba P,D yll a SJ,Park I K,et a.l P heno typ ic

charac teriza ti on o f hu m an co l o recta l cancer ste m ce lls

[J].Proc N atlA cad Sc iU SA,2007,104(24):10158-

10163.

[27]R amasa m y R,Lam E W,Soe i ro I,et a.l M esenchy m a l

stem cell s i nh i b i t proliferati on and apoptosis o f tu mo r

ce lls:i m pact on in vi vo tu m or g row th[J].L eukem i a,

2007,21(2):304-310.

[28]G upta PB,O nder TT,Jiang G,et a.l Identifi cation of

se l ective i nhi b itors o f cance r stem ce lls by h i gh-

throughput screeni ng[J].Ce l,l2009,138(4):645-

659.

#

105

#

实用肿瘤杂志2010年第25卷第1期